Compare Cytokinetics Inc (CYTK) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Wells Fargo & Co — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while Wells Fargo & Co trades at $87.3 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 24.9× Cytokinetics Inc's market cap, and Wells Fargo & Co pays a 2.29% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | WFC | |
|---|---|---|
Market Cap | $10.63B | $264.66B |
Sector | Technology | Financials |
52-Week High | $87.26 | $96.40 |
52-Week Low | $34.31 | $73.42 |
Enterprise Value | $10.74B | — |
Dividend Yield | — | 2.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
